Royalty Pharma (RPRX) announced the appointment of Vlad Coric to the company’s board of directors, effective immediately. Vlad Coric is the ...

The pharma industry's hopes of a sector-wide tariff carve-out faded after Trump last week confirmed that an announcement would come soon, but drugmakers have since been lobbying the ...

With a label expansion for Uplizna pushing the drug into an untouched rare disease market, Amgen is getting its money’s worth ...

RBC Capital analyst Luca Issi maintained a Buy rating on Alnylam Pharma (ALNY – Research Report) on April 3 and set a price target of $330.00. The company’s shares closed yesterday at $235.74.

GameSpot may get a commission from retail offers. Qizilbash told Variety that the Horizon series "just wasn’t creatively going how we wanted to," which led Sony to reevaluate it as a potential ...

Strides Pharma Science Ltd, Aarti Pharma Ltd, Marksans Pharma Ltd, Laurus Labs and IPCA Labs led losers on the BSE Healthcare index, as the party got over in the pharma pack early after the US ...